Order Article Reprints

Stojanović Novković S, Šelemetjev S, Krajnović M, Božović A, Kožik B, Prosenc Zmrzljak U, Išić Denčić T. Implication of p16 Promoter Methylation, the BRAFV600E Mutation, and ETS1 Expression Determination on Papillary Thyroid Carcinoma Prognosis and High-Risk Patients’ Selection. Biomedicines. 2025; 13(7):1583. https://doi.org/10.3390/biomedicines13071583

Stojanović Novković, Stefana, Sonja Šelemetjev, Milena Krajnović, Ana Božović, Bojana Kožik, Uršula Prosenc Zmrzljak, and Tijana Išić Denčić. 2025. "Implication of p16 Promoter Methylation, the BRAFV600E Mutation, and ETS1 Expression Determination on Papillary Thyroid Carcinoma Prognosis and High-Risk Patients’ Selection" Biomedicines 13, no. 7: 1583. https://doi.org/10.3390/biomedicines13071583

Stojanović Novković, S., Šelemetjev, S., Krajnović, M., Božović, A., Kožik, B., Prosenc Zmrzljak, U., & Išić Denčić, T. (2025). Implication of p16 Promoter Methylation, the BRAFV600E Mutation, and ETS1 Expression Determination on Papillary Thyroid Carcinoma Prognosis and High-Risk Patients’ Selection. Biomedicines, 13(7), 1583. https://doi.org/10.3390/biomedicines13071583